{"PubmedArticle": [{"MedlineCitation": {"CitationSubset": ["OM"], "KeywordList": [["ADOLESCENCE", "ALKALOIDS", "ALOPECIA", "ANTINEOPLASTIC AGENTS", "BONE MARROW DISEASES", "BREAST NEOPLASMS", "CHILD", "CHORIOCARCINOMA", "GERIATRICS", "HODGKIN'S DISEASE", "LEUKEMIA", "LYMPHOSARCOMA", "NEUROLOGIC MANIFESTATIONS", "PLANTS, MEDICINAL", "SARCOMA, RETICULUM CELL", "TOXICOLOGIC REPORT", "VINBLASTINE", "VINCRISTINE"]], "GeneralNote": [], "InvestigatorList": [], "OtherID": [], "OtherAbstract": [], "SpaceFlightMission": [], "PMID": "14158543", "DateCompleted": {"Year": "1996", "Month": "12", "Day": "01"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "01"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0008-4409", "JournalIssue": {"Volume": "90", "Issue": "25", "PubDate": {"Year": "1964", "Month": "Jun", "Day": "20"}}, "Title": "Canadian Medical Association journal", "ISOAbbreviation": "Can Med Assoc J"}, "ArticleTitle": "VINCRISTINE IN THE TREATMENT OF NEOPLASTIC DISEASE.", "Pagination": {"StartPage": "1385", "EndPage": "1389", "MedlinePgn": "1385-9"}, "Abstract": {"AbstractText": ["Seventy-eight patients with advanced malignant disease were treated with vincristine, an alkaloid derived from Vinca rosea Linn. Fifty-nine of these survived one month from the beginning of treatment and could be evaluated. Twenty made a good response, with return to activity and more than 75% regression of tumour deposits. Seven made a fair response with resumption of partial activity and at least a 25% regression of tumour deposits. Favourable results were seen in patients with Hodgkin's disease, reticulum cell sarcoma, lymphosarcoma, carcinoma of the breast, acute leukemia and choriocarcinoma. The duration of remission was usually brief but in five instances exceeded six months. Toxic reactions include a high incidence of alopecia and neurologic complications. The bone marrow depression is constant and predictable."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "WHITELAW", "ForeName": "D M", "Initials": "DM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "KIM", "ForeName": "H S", "Initials": "HS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Canada", "MedlineTA": "Can Med Assoc J", "NlmUniqueID": "0414110", "ISSNLinking": "0008-4409"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "5J49Q6B70F", "NameOfSubstance": "Vincristine"}, {"RegistryNumber": "5V9KLZ54CY", "NameOfSubstance": "Vinblastine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Alopecia"}, {"QualifierName": [], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Bone Marrow Diseases"}, {"QualifierName": [], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Carcinoma"}, {"QualifierName": [], "DescriptorName": "Child"}, {"QualifierName": [], "DescriptorName": "Choriocarcinoma"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Geriatrics"}, {"QualifierName": [], "DescriptorName": "Hodgkin Disease"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Leukemia"}, {"QualifierName": [], "DescriptorName": "Lymphoma"}, {"QualifierName": [], "DescriptorName": "Lymphoma, Large B-Cell, Diffuse"}, {"QualifierName": [], "DescriptorName": "Lymphoma, Non-Hodgkin"}, {"QualifierName": [], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Neurologic Manifestations"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": [], "DescriptorName": "Sarcoma"}, {"QualifierName": [], "DescriptorName": "Toxicology"}, {"QualifierName": [], "DescriptorName": "Vinblastine"}, {"QualifierName": [], "DescriptorName": "Vincristine"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ann N Y Acad Sci. 1958 Dec 5;76(3):882-94", "ArticleIdList": ["13627916"]}, {"Citation": "Proc R Soc Med. 1960 Dec;53:1032-4", "ArticleIdList": ["13783269"]}, {"Citation": "Can Med Assoc J. 1961 Sep 2;85:584-91", "ArticleIdList": ["13784890"]}, {"Citation": "Cancer Res. 1963 May;23:613-21", "ArticleIdList": ["13968454"]}, {"Citation": "JAMA. 1963 Mar 2;183:741-6", "ArticleIdList": ["13992692"]}, {"Citation": "Blood. 1963 May;21:640-7", "ArticleIdList": ["14018556"]}, {"Citation": "Cancer Chemother Rep. 1962 Nov;24:39-44", "ArticleIdList": ["14023264"]}, {"Citation": "Lancet. 1963 Nov 23;2(7317):1080-3", "ArticleIdList": ["14063417"]}, {"Citation": "Cancer. 1963 Oct;16:1302-6", "ArticleIdList": ["14074214"]}, {"Citation": "Cancer Chemother Rep. 1964 Jan;34:21-3", "ArticleIdList": ["14116215"]}, {"Citation": "Cancer Chemother Rep. 1964 Jan;34:25-30", "ArticleIdList": ["14116216"]}, {"Citation": "Exp Cell Res. 1960 Jun;20:198-201", "ArticleIdList": ["14429980"]}, {"Citation": "Cancer Res. 1960 Aug;20:1041-9", "ArticleIdList": ["14402218"]}], "ReferenceList": []}], "History": [{"Year": "1964", "Month": "6", "Day": "20"}, {"Year": "1964", "Month": "6", "Day": "20", "Hour": "0", "Minute": "1"}, {"Year": "1964", "Month": "6", "Day": "20", "Hour": "0", "Minute": "0"}, {"Year": "1964", "Month": "6", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["14158543", "PMC1927246"]}}], "PubmedBookArticle": []}